Quelques sites internet traitant de l’aide à
la décision en innovation pharmaceutique
 Principes de base de la découverte et du développement d’un médicament
www.montrealinternational.com/sciences/medicament/principes.html
Tufts Center for the Study of Drug Development
http://csdd.tufts.edu/
MIT Center for Biomedical Innovation:
http://web.mit.edu/cbi
European Federation of Biotechnology, Section of Medicines Development, New Safe Medicine Faster (NSMF)
www.nsmf.org
Initiative Médicaments innovants (IMI, Commission européenne)
http://ec.europa.eu/research/health/imi/index_en.html
IMI (EFPIA)
www.imi-europe.org
FDA's Critical Path Initiative
www.fda.gov/oc/initiatives/criticalpath
Critical Path Institute
www.c-path.org
The Biomarkers Consortium (Foundation for the NIH)
www.fnih.org/Biomarkers%20Consortium/Biomarkers_home.shtml
Eurasanté (2004) Les biomarqueurs dans le développement du médicament
www.eurasante.com/fileadmin/templates/web/pdf-publications/Les-biomarqueurs-dans-le-developpement-du-medicament_Eurasan.pdf
M.R. Trusheim et al. (2007) Stratified Medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nat Rev Drug Discov. 6, 287-293.
http://web.mit.edu/cbi/publications/Trusheim_Berndt_Douglas.pdf
J. Luo (2007) Multiplex Analysis of Drug Toxicity Markers, A Novel Methodology Advances Gene Expression Profiling Research, Genetic Engineering & Bioetchnology News
www.genengnews.com/articles/chtitem.aspx?tid=2039&chid=1
K. Liszewski (2006) Drug Discovery: Successful Lead Optimization Strategies, Line Begins to Blur with Lead Discovery, Genetic Engineering & Bioetchnology News
www.genengnews.com/articles/chitem.aspx?aid=1825&chid=1
Revue Nature Reviews Drug Discovery, quelques articles en libre accès
www.nature.com/nrd
 Introduction  Chapitre 1 Chapitre 2
Sommaire
|
